Cargando…
Telemonitoring, Telemedicine and Time in Range During the Pandemic: Paradigm Change for Diabetes Risk Management in the Post-COVID Future
People with diabetes are at greater risk for negative outcomes from COVID-19. Though this risk is multifactorial, poor glycaemic control before and during admission to hospital for COVID-19 is likely to contribute to the increased risk. The COVID-19 pandemic and restrictions on mobility and interact...
Autores principales: | Danne, Thomas, Limbert, Catarina, Puig Domingo, Manel, Del Prato, Stefano, Renard, Eric, Choudhary, Pratik, Seibold, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327601/ https://www.ncbi.nlm.nih.gov/pubmed/34338994 http://dx.doi.org/10.1007/s13300-021-01114-x |
Ejemplares similares
-
COVID-19, type 1 diabetes, and technology: why paediatric patients are leading the way
por: Danne, Thomas, et al.
Publicado: (2020) -
Monitoring of COVID-19 patients via telemedicine with telemonitoring()
por: Martínez-García, M., et al.
Publicado: (2020) -
Efficacy of Telemedicine and Telemonitoring in At-Home Monitoring of Patients with COVID-19
por: Casariego-Vales, Emilio, et al.
Publicado: (2021) -
Continuous glucose monitoring‐based time‐in‐range using insulin glargine 300 units/ml versus insulin degludec 100 units/ml in type 1 diabetes: The head‐to‐head randomized controlled InRange trial
por: Battelino, Tadej, et al.
Publicado: (2022) -
Telemedicine in the management of hypertension: Evolving technological platforms for blood pressure telemonitoring
por: Wang, Ji‐Guang, et al.
Publicado: (2021)